Intuitive Surgical Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (76)

Latest Posts

About This Stock More About This Stock
The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs
Article By: Benzinga
Sunday, July 18, 2021 11:25 AM EDT
Biotech stocks were down for a second week in a row, as they retreated along with the broader market amid macro concerns. Consumer price inflation data released during the week stoked rate hike fears, and exerted negative pressure on stocks.
In this article: ABT, DGX, JNJ, LLY, NURO, BIIB, ISRG, FGEN, ALBO, MRNA
Read
3 Large-Cap Growth Stocks To Add To Your Portfolio This Summer
Article By: StockNews
Friday, July 9, 2021 9:26 AM EDT
Even though investors rotated away from expensive growth stocks earlier this year, select growth stocks have been experiencing strong rebounds and in some instances are making new highs.
In this article: ILMN, ISRG, EW Also: SPYG
Read
Will Intuitive Surgical Ever Pay A Dividend?
Article By: SureDividend
Thursday, December 3, 2020 2:49 PM EDT
Intuitive Surgical’s profit base is quite significant and growing. But for income-focused investors, Intuitive Surgical may not be the right choice.
In this article: ISRG
Read
4 Innovative Companies To Own For 2021
Article By: StockNews
Friday, October 30, 2020 6:54 PM EDT
Many innovative companies are “building the future”. These stocks also offer the best returns to investors. Some future innovations that could affect daily life are virtual reality, augmented reality, electric cars, autonomous driving, and robotics.
In this article: ISRG, TSLA, SNAP, FB Also: XITK
Read
5 Important Earnings Chart To Watch This Week
Video By: Tracey Ryniec
Thursday, October 15, 2020 6:00 AM EDT
Third-quarter earnings season is upon us.
In this video: KSU, SLB, VFC, ISRG, WBA
Watch

Latest Tweets for $ISRG

No tweets yet!

PARTNER HEADLINES

$ISRG

Sell These Three Healthcare Stocks Now
Wall St. Wolf 5/30/2020 8:53:27 PM

Mr Elfenbein writes about $ISRG: " I want to be clear that I’m a fan of this company. In fact, a big fan."

Where is the objectivity here? Where are the facts, figures and comparisons? He only quotes from analysts and people involved in the company. I was disappointed in the article.

1 to 1 of 1 comments